Enalapril/hydrochlorothiazide

Enalapril/hydrochlorothiazide

Combination of
Enalapril	ACE inhibitor
Hydrochlorothiazide	Thiazide diuretic
Clinical data
Trade names	Vaseretic, others
AHFS/Drugs.com	Monograph
MedlinePlus	a601047
License data	US  DailyMed:  Enalapril maleate and hydrochlorothiazide
Pregnancy category	AU:D [1]
Routes of administration	By mouth
ATC code	C09BA02 ( WHO )
Legal status
Legal status	US: ℞-only [2] In general: ℞ (Prescription only)
Identifiers
KEGG	D10277

Enalapril/hydrochlorothiazide, sold under the brand name Vaseretic among others, is a fixed-dose combination medication used for the treatment of hypertension (high blood pressure). ^[2] It contains enalapril, an angiotensin converting enzyme inhibitor, and hydrochlorothiazide a diuretic. ^[2] It is taken by mouth. ^[2]

The most frequent side effects include dizziness, headache, fatigue, and cough. ^[2]

History

Enalapril/hydrochlorothiazide was approved for medical use in the United States in October 1986. ^{[2] [3]}

References

1. "Enalapril / hydrochlorothiazide (Vaseretic) Use During Pregnancy". Drugs.com. 29 May 2019. Retrieved 26 April 2020.
2. "Vaseretic- enalapril maleate and hydrochlorothiazide tablet". DailyMed. Retrieved 7 February 2022.
3. "Vaseretic: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 1 May 2017. Retrieved 26 April 2020.

Further reading

• Frishman WH, Goldberger J, Sherman D (December 1987). "Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension". J Clin Hypertens. 3 (4): 520–7. PMID   2839628.